We are live on ! Find out more
VIA

Vident Investment Advisory Portfolio holdings

AUM $2.9B
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+1.13%
1 Year Est. Return
+24.67%
3 Year Est. Return
+82.63%
5 Year Est. Return
+113.33%
10 Year Est. Return
AUM
$2.46B
AUM Growth
+$238M
Cap. Flow
+$217M
Cap. Flow %
8.81%
Top 10 Hldgs %
17.01%
Holding
976
New
195
Increased
478
Reduced
214
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 28.44%
2 Industrials 13.87%
3 Healthcare 11.83%
4 Consumer Discretionary 8.52%
5 Financials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BECN
251
DELISTED
Beacon Roofing Supply, Inc.
BECN
$2.9M 0.12%
+55,540
New +$3.19M
CRUS icon
252
Cirrus Logic
CRUS
$6.26B
$2.88M 0.12%
72,688
+28,733
+65% +$1.33M
ADAP
253
DELISTED
Adaptimmune Therapeutics
ADAP
$2.87M 0.12%
231,349
+61,943
+37% +$542K
BMY icon
254
Bristol-Myers Squibb
BMY
$132B
$2.86M 0.12%
53,174
+6,180
+13% +$398K
XHR
255
Xenia Hotels & Resorts
XHR
$1.79B
$2.86M 0.12%
139,771
-2,413
-2% -$50K
LHCG
256
DELISTED
LHC Group LLC
LHCG
$2.86M 0.12%
40,046
+3,290
+9% +$208K
KBR icon
257
KBR
KBR
$4.8B
$2.83M 0.12%
+165,160
New +$3M
MANT
258
DELISTED
Mantech International Corp
MANT
$2.81M 0.11%
+47,149
New +$2.52M
CASY icon
259
Casey's General Stores
CASY
$30.9B
$2.79M 0.11%
27,264
+8,237
+43% +$953K
GPI icon
260
Group 1 Automotive
GPI
$3.18B
$2.77M 0.11%
+43,440
New +$3.22M
EHC icon
261
Encompass Health
EHC
$12.4B
$2.76M 0.11%
+60,242
New +$2.58M
DAN icon
262
Dana Inc
DAN
$3.06B
$2.75M 0.11%
103,603
-12,767
-11% -$378K
JNCE
263
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.75M 0.11%
133,825
+36,359
+37% +$807K
GHC icon
264
Graham Holdings Company
GHC
$5.02B
$2.75M 0.11%
4,467
+278
+7% +$163K
PPC icon
265
Pilgrim's Pride
PPC
$6.54B
$2.74M 0.11%
113,571
-3,021
-3% -$81.1K
PRGO icon
266
Perrigo
PRGO
$1.78B
$2.72M 0.11%
33,533
+17,337
+107% +$1.51M
BIG
267
DELISTED
Big Lots, Inc.
BIG
$2.67M 0.11%
62,155
+1,328
+2% +$72.8K
VVR icon
268
Invesco Senior Income Trust
VVR
$454M
$2.66M 0.11%
+602,683
New +$2.67M
THO icon
269
Thor Industries
THO
$4.14B
$2.65M 0.11%
+25,126
New +$3.36M
OXM icon
270
Oxford Industries
OXM
$552M
$2.64M 0.11%
33,971
+2,635
+8% +$211K
RRX icon
271
Regal Rexnord
RRX
$11.9B
$2.64M 0.11%
35,574
+3,268
+10% +$246K
DPLO
272
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$2.62M 0.11%
129,583
-20,921
-14% -$488K
HOUS
273
DELISTED
Anywhere Real Estate
HOUS
$2.61M 0.11%
99,155
+10,310
+12% +$271K
MEI icon
274
Methode Electronics
MEI
$592M
$2.6M 0.11%
65,505
+6,661
+11% +$270K
CNA icon
275
CNA Financial
CNA
$14.1B
$2.58M 0.1%
51,965
+4,697
+10% +$246K

Similar funds

Vident Investment Advisory's Q1 2018 Portfolio in Review

As of Q1 2018, Vident Investment Advisory held 976 positions worth $2.46B, up 11% from $2.22B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Vident Investment Advisory deployed $217M of net new capital in Q1 2018, opening 195 new positions and adding to 478 existing holdings. Its largest new stake was NexPoint Diversified Real Estate Trust: 340,420 shares worth $7.83M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $59.4M trimmed.

  • Vident Investment Advisory's largest Q1 2018 buy was NexPoint Diversified Real Estate Trust: 340,420 shares worth $7.83M.
  • Vident Investment Advisory added most to Cognex in Q1 2018, an estimated $18.8M increase.
  • Vident Investment Advisory's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $59.4M.
  • Vident Investment Advisory fully exited Eaton Vance Tax-Advantaged Global Dividend Income Fund in Q1 2018, selling an estimated $10.7M.
  • Vident Investment Advisory's ten largest holdings make up 17% of its $2.46B portfolio in Q1 2018.
  • Vident Investment Advisory opened 195 new positions and closed 88 in Q1 2018.
  • Vident Investment Advisory's portfolio value rose 11% quarter-over-quarter to $2.46B.

Based on Vident Investment Advisory's 13F filing for Q1 2018, filed 14 May 2018.